Sutro Biopharma Stock Probability of Future Stock Price Finishing Over 13.98
| STRO Stock | USD 13.98 1.54 9.92% |
Closest to current price Sutro long PUT Option Payoff at Expiration
Sutro Biopharma Target Price Odds to finish over 13.98
The tendency of Sutro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 13.98 | 90 days | 13.98 | about 13.6 |
Based on a normal probability distribution, the odds of Sutro Biopharma to move above the current price in 90 days from now is about 13.6 (This Sutro Biopharma probability density function shows the probability of Sutro Stock to fall within a particular range of prices over 90 days) .
Sutro Biopharma Price Density |
| Price |
Predictive Modules for Sutro Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sutro Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sutro Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sutro Biopharma is not an exception. The market had few large corrections towards the Sutro Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sutro Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sutro Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.55 | |
β | Beta against Dow Jones | 1.40 | |
σ | Overall volatility | 2.64 | |
Ir | Information ratio | 0.09 |
Sutro Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sutro Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sutro Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sutro Biopharma is way too risky over 90 days horizon | |
| Sutro Biopharma appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 62.04 M. Net Loss for the year was (227.46 M) with profit before overhead, payroll, taxes, and interest of 274.15 M. | |
| Sutro Biopharma currently holds about 225.64 M in cash with (191.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.33. | |
| Sutro Biopharma has a strong financial position based on the latest SEC filings | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Heres Why Were A Bit Worried About Sutro Biopharmas Cash Burn Situation |
Sutro Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sutro Stock often depends not only on the future outlook of the current and potential Sutro Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sutro Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.7 M | |
| Cash And Short Term Investments | 316.9 M |
Sutro Biopharma Technical Analysis
Sutro Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Sutro Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sutro Biopharma. In general, you should focus on analyzing Sutro Stock price patterns and their correlations with different microeconomic environments and drivers.
Sutro Biopharma Predictive Forecast Models
Sutro Biopharma's time-series forecasting models is one of many Sutro Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sutro Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sutro Biopharma
Checking the ongoing alerts about Sutro Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sutro Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sutro Biopharma is way too risky over 90 days horizon | |
| Sutro Biopharma appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 62.04 M. Net Loss for the year was (227.46 M) with profit before overhead, payroll, taxes, and interest of 274.15 M. | |
| Sutro Biopharma currently holds about 225.64 M in cash with (191.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.33. | |
| Sutro Biopharma has a strong financial position based on the latest SEC filings | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Heres Why Were A Bit Worried About Sutro Biopharmas Cash Burn Situation |
Check out Sutro Biopharma Analysis, Sutro Biopharma Valuation, Sutro Biopharma Correlation, Sutro Biopharma Hype Analysis, Sutro Biopharma Volatility, Sutro Biopharma Price History as well as Sutro Biopharma Performance. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Will Biotechnology sector continue expanding? Could Sutro diversify its offerings? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sutro Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets | Return On Equity |
Understanding Sutro Biopharma requires distinguishing between market price and book value, where the latter reflects Sutro's accounting equity. The concept of intrinsic value - what Sutro Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Sutro Biopharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sutro Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.